Werbung

Werbung

PTGX

Protagonist Therapeutics, Inc

112.46

USD

+2.68

+2.44%

15. Juni, 15:59 UTC -4

Geschlossen

exchange

Nach-Markt

112.52

+0.06

+0.05%

Protagonist Therapeutics, Inc Finanzieller Schnappschuss

Markt Cap	7.24B
Beta	2.12
Gewinn pro Aktie (EPS)	-2.05
Kurs-Buchwert-Verhältnis (P/B)	10.59
Operative Marge	-282.83%

Gesamtverschuldung/Eigenkapital (D/E)	0.00%
Kurs-Gewinn-Verhältnis	--
Eigenkapitalrendite (ROE)	-19.89%
Aktuelles Verhältnis	12.71%
Freier Cash Flow	56.08M

Ertragsdiagramm

Aktien im Trend

Space Exploration Technologies Corp. Class A Common Stock$192.50

+19.60%

Micron Technology, Inc.$1087.99

+10.84%

Nvidia Corp$212.45

+3.54%

Sandisk Corporation Common Stock$2107.86

+6.45%

Tesla, Inc. Common Stock$411.15

+1.16%

Advanced Micro Devices$547.26

+6.98%

Intel Corp$127.86

+2.64%

Werbung